References
- Kim T-D, Song K-S, Li G, Choi H, Park H-D, et al.: Activity and expression of urokinase-type plasminogen activator and matrix metalloproteinases in human colorectal cancer. BMC Cancer 6, 211, 2006.
- Zhao J and Guan J-L: Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 28, 35–49, 2009.
- Owens LV, Xu L, Craven RJ, Dent GA, Weiner TM, et al.: Overexpression of the focal adhesion kinase (p125fak) in invasive human tumors. Cancer Res 55, 2752–2755, 1995.
- van Nimwegen MJ and van de Water B: Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol 73, 597–609, 2007.
- Hauck CR, Hsia DA, and Schlaepfer DD : The focal adhesion kinase-a regulator of cell migration and invasion. IUBMB Life 53, 115–119, 2002.
- Lee BY, Timpson P, Horvath LG, and Daly RJ: Fak signaling in human cancer as a target for therapeutics. Pharmacol Therapeutics 146, 132–149, 2015.
- Fong Y-C, Liu S-C, Huang C-Y, Li T-M, Hsu S-F, et al.: Osteopontin increases lung cancer cells migration via activation of the αvβ3 integrin/fak/akt and nf-κb-dependent pathway. Lung Cancer 64, 263–270, 2009.
- Zubair A and Frieri M: Role of nuclear factor nf-ĸb in breast and colorectal cancer. Curr Allergy Asthma Rep 13, 1–6, 2013.
- Hassanzadeh P: Colorectal cancer and nf-κb signaling pathway. Gastroenterol Hepatol Bed Bench 4, 127, 2011.
- Lee CH, Jeon Y-T, Kim S-H, and Song Y-S : NF-kappaB as a potential molecular target for cancer therapy. Biofactors 29, 19–35, 2007.
- Adamsen BL, Kravik L, and De Angelis PM: Cellular response to chemoradiotherapy, radiotherapy and chemotherapy in two colorectal cancer cell lines. Radiat Res 171, 562–571, 2009.
- Longley DB, Allen WL, and Johnston PG: Drug resistance, predictive markers and pharmacogenomics in colorectal cancer. Biochim Biophys Acta (BBA): Rev Cancer 1766, 184–196, 2006.
- Safarzadeh E, Shotorbani SS, and Baradaran B: Herbal medicine as inducers of apoptosis in cancer treatment. Adv Pharm Bull 4, 421, 2014.
- Alitheen N, Mashitoh A, Yeap S, Shuhaimi M, Manaf AA, and Nordin L: Cytotoxic effect of damnacanthal, nordamnacanthal, zerumbone and betulinic acid isolated from Malaysian plant sources. Int Food Res J 17, 711–719, 2010.
- Sulaiman M, Perimal E, Akhtar M, Mohamad A, Khalid M, et al.: Anti-inflammatory effect of zerumbone on acute and chronic inflammation models in mice. Fitoterapia 81, 855–858, 2010.
- Rahman HS, Rasedee A, Yeap SK, Othman HH, Chartrand MS, et al.: Biomedical properties of a natural dietary plant metabolite, zerumbone, in cancer therapy and chemoprevention trials. BioMed Res Int 2014, 1, 2014.
- Wenhong D, Jia Y, Weixing W, Xiaoyan C, Chen C, et al.: Zerumbone attenuates the severity of acute necrotizing pancreatitis and pancreatitis-induced hepatic injury. Mediators Inflamm 2012, 1, 2012.
- Tong W, Wang Q, Sun D, and Suo J: Curcumin suppresses colon cancer cell invasion via ampk-induced inhibition of nf-κb, upa activator and mmp9. Oncol Lett 12, 4139–4146, 2016.
- Gupta SC, Kim JH, Prasad S, and Aggarwal BB: Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29, 405–434, 2010.
- Sung B, Jhurani S, Ahn KS, Mastuo Y, Yi T, et al.: Zerumbone down-regulates chemokine receptor cxcr4 expression leading to inhibition of cxcl12-induced invasion of breast and pancreatic tumor cells. Cancer Res 68, 8938–8944, 2008.
- Kim S, Lee J, Jeon M, Lee JE, and Nam SJ: Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway. Oncotarget 7, 1544, 2016.
- Prasannan R, Kalesh KA, Shanmugam MK, Nachiyappan A, Ramachandran L, et al.: Key cell signaling pathways modulated by zerumbone: role in the prevention and treatment of cancer. Biochem Pharmacol 84, 1268–1276, 2012.
- Rahman HS, Rasedee A, How CW, Abdul AB, Zeenathul NA, et al.: Zerumbone-loaded nanostructured lipid carriers: preparation, characterization, and antileukemic effect. Int J Nanomed 8, 2769, 2013.
- Sadhu SK, Khatun A, Ohtsuki T, and Ishibashi M: First isolation of sesquiterpenes and flavonoids from zingiber spectabile and identification of zerumbone as the major cell growth inhibitory component. Natural Product Res 21, 1242–1247, 2007.
- Hoffman A, Spetner L, and Burke M: Redox-regulated mechanism may account for zerumbone’s ability to suppress cancer-cell proliferation. Carcinogenesis 23, 1961–1962, 2002.
- Murakami A, Takahashi D, Kinoshita T, Koshimizu K, Kim HW, et al.: Zerumbone, a southeast asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the α, β-unsaturated carbonyl group is a prerequisite. Carcinogenesis 23, 795–802, 2002.
- Deorukhkar A, Ahuja N, Mercado A, Diagaradjane P, Mohindra P, et al.: Zerumbone, a sesquiterpene from southeast Asian edible ginger sensitizes colorectal cancer cells to radiation therapy. Int J Radiat Oncol Biol Phys 78, S654, 2010.
- Yodkeeree S, Sung B, Limtrakul P, and Aggarwal BB: Zerumbone enhances trail-induced apoptosis through the induction of death receptors in human colon cancer cells: evidence for an essential role of reactive oxygen species. Cancer Res 69, 6581–6589, 2009.
- Tang H, Kerins DM, Hao Q, Inagami T, and Vaughan DE: The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J Biol Chem 273, 18268–18272, 1998.
- Lin H-J, Su C-C, Lu H-F, Yang J-S, Hsu S-C, et al.: Curcumin blocks migration and invasion of mouse-rat hybrid retina ganglion cells (n18) through the inhibition of mmp-2,-9, fak, rho a and rock-1 gene expression. Oncol Rep 23, 665–670, 2010.
- Chen C-C, Sureshbabul M, Chen H-W, Lin Y-S, Lee J-Y, et al.: Curcumin suppresses metastasis via sp-1, fak inhibition, and e-cadherin upregulation in colorectal cancer. Evidence-Based Complement Alternat Med 2013, 1, 2013.
- Liao CH, Sang S, Ho CT, and Lin JK: Garcinol modulates tyrosine phosphorylation of fak and subsequently induces apoptosis through down‐regulation of src, erk, and akt survival signaling in human colon cancer cells. J Cell Biochem 96, 155–169, 2005.
- Chakraborty A, Coffman R, and Jorvig J: Zerumbone, a phytochemical from asian ginger is a novel inhibitor of jak2/stat3 inhibits promigratory gene expression, growth and migration of pancreatic cancer cells. Pancreatology 13, e18–e19, 2013.
- Kang CG, Lee H-J, Kim S-H, and Lee E-O: Zerumbone suppresses osteopontin-induced cell invasion through inhibiting the fak/akt/rock pathway in human non-small cell lung cancer a549 cells. J Nat Prod 79, 156–160, 2016.
- Takada Y, Murakami A, and Aggarwal BB: Zerumbone abolishes nf-[kappa] b and i [kappa] b [alpha] kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene 24, 6957, 2005.
- Shamoto T, Matsuo Y, Shibata T, Tsuboi K, Nagasaki T, et al.: Zerumbone inhibits angiogenesis by blocking nf-κb activity in pancreatic cancer. Pancreas 43, 396–404, 2014.
- Tsuboi K, Matsuo Y, Shamoto T, Shibata T, Koide S, et al.: Zerumbone inhibits tumor angiogenesis via nf-κb in gastric cancer. Oncol Rep 31, 57–64, 2014.
- Nowicki TS, Zhao H, Darzynkiewicz Z, Moscatello A, Shin E, et al.: Downregulation of upar inhibits migration, invasion, proliferation, fak/pi3k/akt signaling and induces senescence in papillary thyroid carcinoma cells. Cell Cycle 10, 100–107, 2011.